Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics

NCT06435481 is registered in ClinicalTrials.gov with Hospital Universitari Vall d'Hebron Research Institute as lead sponsor.

NCT NCT06435481
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06435481 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability and Acceptance of Two Oral Hydrocortisone Compounding Formulation for Pediatrics
Lead sponsor
Hospital Universitari Vall d'Hebron Research Institute
Phase
Phase 4
Overall status
Not yet recruiting
Start date
September 30, 2024
Completion date
September 30, 2026
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

adrenal insufficiency